Medtronic has launched an exchange offer allowing its shareholders to swap their Medtronic shares for MiniMed Group shares at a 7% discount, expected to be tax-free for U.S. federal income tax purposes. MiniMed, formerly Medtronic's Diabetes business, went public in March 2026 with Medtronic retaining about 90% ownership. This move aims to spin off at least 80.1% of MiniMed shares, enabling MiniMed to operate independently and allowing Medtronic to focus on its Cardiovascular, Neuroscience, and Surgical divisions. The offer is voluntary, with conditions including a minimum number of shares tendered and legal tax opinions, and is expected to conclude around October 9, 2026.
Medtronic announced a final exchange ratio of 4.5939 MiniMed shares for each Medtronic ordinary share in its offer to exchange shares. The offer includes up to 225 million MiniMed shares and may extend to an additional 27 million shares if oversubscr...
In 2026, both Medtronic and Abbott stocks have declined, altering their dividend yields and valuations. Medtronic now offers a higher dividend yield of 3.3% versus Abbott's 2.56%, making it more attractive for retirees needing income. Abbott, however...
